RSH-7
RSH-7 is a potent BTK and FLT3 inhibitor with IC50s of 47, 12 nM, respectively. RSH-7 induces apoptosis and shows antiproliferative activities. RSH-7 inhibits BTK and FLT3 signaling and shows anti-tumor activity[1].
Product Specifications
CAS Number
2764609-97-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Btk; FLT3
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rsh-7.html
Purity
99.07
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC(NC4=C(C=CC=C4)C(NN)=O)=C(C=N3)F
Molecular Formula
C22H25FN8O
Molecular Weight
436.49
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Ran F, et al. Development of novel hydrazidoarylaminopyrimidine-based BTK/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects. Eur J Med Chem. 2023 Jan 5;245 (Pt 1) :114913.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY419178 100 µg
MCH (PMCH) (NM_002674) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC042308-100 1x 100 µL
HSP27 (Heat Shock Protein 27) (rHSPB1/774), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 